- Establish Fludon H1 become lead brands in Vietnam in the market segment of treatment influenza.

- Contributing to join in prevention and treatment of influenza in the community through funding 10 million capsules of Fludon H1 50mg and 6 million capsules of Fludon H1 200mg for National programs in prevention and treatment of influenza A/ H1N1 within 03 years time from the date of the Ministry of health issue the registration number;

- In 2010 and 2012, production to over 100 million capsules of Fludon H1 for the prevention and treatment of influenza A/H1N1 in Vietnam;

- Image storage material for production over 50 million capsules of Fludon H1 for the prevention influenza epidemic outbreaks in Vietnam in 2010-2012;

- Maintaining the research:

Optimize dosage form;

Synthesis Arbidol on industrial scale;

- Research Project of Development factory produce Arbidol to:

Contributing to ensure security on the health aspects in the national defense in prevention and treatment of influenza A/H1N1 in Vietnam;

Supplying proactively antiviral drugs for the treatment of domestic and export;

Lower price of products;